ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience / 부인종양
Journal of Gynecologic Oncology
;
: 6-2020.
Article
in English
| WPRIM
| ID: wpr-782096
ABSTRACT
1.1 g/dL, estimated glomerular filtration rate (eGFR) ≤60 mL/min, ≥3 comorbidities were independently associated with a higher severe toxicity.CONCLUSIONS:
Elderly patients with EOC can safely be treated with bevacizumab; factors other than age, as higher creatinine serum levels, eGFR and number of comorbidities should be considered to better estimate bevacizumab-related toxicity risk.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Ovarian Neoplasms
/
Case-Control Studies
/
Comorbidity
/
Logistic Models
/
Creatinine
/
Diagnosis
/
Drug Therapy
/
Bevacizumab
/
Glomerular Filtration Rate
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Aged
/
Female
/
Humans
Language:
English
Journal:
Journal of Gynecologic Oncology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS